Skip to main content

Posts

Showing posts from April, 2026

New ACC Guidance on Obesity and Cardiovascular Disease: What Every NP Needs to Know

New ACC Guidance on Obesity and Cardiovascular Disease: What Every NP Needs to Know If you're a nurse practitioner in primary care, family practice, or cardiology, you already know that the obesity conversation has fundamentally changed. We're no longer in the era of "eat less, move more" as the sole clinical recommendation. The American College of Cardiology dropped two major guidance documents in August 2025 that every NP managing cardiovascular risk needs to have on their radar — and if you missed them, consider this your clinical catch-up. Let's break down what matters for your practice. Two Documents, One Clear Message The ACC released a Concise Clinical Guidance (CCG) on the medical management of obesity and a Scientific Statement focused specifically on treating obesity in adults with heart failure. Both documents signal a seismic shift in how we should be thinking about weight management as a core component of cardiovascular care — not a side conv...

Choosing the Right Antidepressant Just Got a Little Easier: What NPs Need to Know About the PETRUSHKA Trial

  Psychiatry & Mental Health Choosing the Right Antidepressant Just Got a Little Easier: What NPs Need to Know About the PETRUSHKA Trial A new decision-support tool helped patients stay on their antidepressant longer and feel better at six months. Here's what it means for your prescribing practice. If you've ever stared at a list of SSRIs and SNRIs wondering which one will actually work for the patient sitting across from you, you're not alone. The antidepressant selection process has long been described as "educated trial and error," and for good reason—we've had limited tools to meaningfully guide that first-line choice. A large new randomized trial published in  JAMA  in March 2026 offers some encouraging evidence that a structured, personalized approach can improve outcomes. The Study at a Glance Cipriani and colleagues conducted a multicenter RCT across 47 sites in Brazil, Canada, and the UK, enrolling 540 adults aged 18–74 with major depressive disor...

Delivering a Down Syndrome Diagnosis with Confidence and Compassion: AAP Guidelines Meet the SPIKES Strategy

  Delivering a Down Syndrome Diagnosis with Confidence and Compassion: AAP Guidelines Meet the SPIKES Strategy If you've ever had to deliver difficult news to a patient or family — and let's be honest, most of us have — you know the weight of those moments. The clinical knowledge matters, but how you communicate can shape a family's trajectory for years to come. A powerful session at the NAPNAP 2026 National Conference in Pittsburgh brought this truth into sharp focus, pairing the updated AAP health supervision guidelines for Down syndrome with a structured communication framework called SPIKES. The session was co-presented by Kristina Banks, DNP, MSN, APRN, CPNP-PC, Specialty Director of Pediatric Nurse Practitioner programs at Case Western University, and Katharine Roanleigh, MSN, APRN, FNP-BC, CPNP-PC — a fellow NP who received a prenatal Down syndrome diagnosis for her own son in December 2023. Together, they modeled what evidence-based care looks like when it's...

The 2026 ACC/AHA Dyslipidemia Guidelines: Everything Primary Care NPs Need to Know Right Now

  Clinical Updates · Cardiology The 2026 ACC/AHA Dyslipidemia Guidelines: Everything Primary Care NPs Need to Know Right Now A comprehensive clinical breakdown of the most significant cholesterol guideline update in nearly a decade. Published April 2026 · NP Chronicles · 12-minute read · Updated from the 2018 ACC/AHA Guideline The 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia dropped this spring — and if you manage patients with cardiovascular risk in primary care, this one is going to change your practice. Here's what you need to know, translated for the clinic floor. Whether you're seeing a 45-year-old with a new diabetes diagnosis, a 58-year-old post-MI patient not at LDL goal, or a young woman with a family history of premature heart disease, the 2026 guidelines give us clearer targets, updated risk tools, and several entirely new recommendations that simply didn't exist before. Let's break it down. 📋 Quick Cont...